Under construction – not a live service

Skip to content

Frontlight Research

Trial site

UMHAT Alexandrovska EAD /ID# 231056

Sofiya, Sofia 1431, BulgariaEU-13 widening countryNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Myeloproliferative neoplasms

Closed trials

Completed
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
NCT04472598· Phase 3· AbbVie· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – UMHAT Alexandrovska EAD /ID# 231056: trial site – Frontlight Research